We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+6.55%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.64%
AUM
$4.05B
AUM Growth
+$375M
Cap. Flow
+$164M
Cap. Flow %
4.05%
Top 10 Hldgs %
45.11%
Holding
463
New
50
Increased
205
Reduced
169
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 64.3%
2 Technology 14.03%
3 Healthcare 5.35%
4 Financials 4.48%
5 Communication Services 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVO
101
Novo Nordisk
NVO
$205B
$6.31M 0.16%
113,752
-11,604
-9% -$679K
MKC icon
102
McCormick & Company Non-Voting
MKC
$14.7B
$6.24M 0.15%
93,247
-3,379
-3% -$237K
WDAY icon
103
Workday
WDAY
$47.8B
$6.24M 0.15%
25,902
-3,343
-11% -$773K
CMCSA icon
104
Comcast
CMCSA
$93.7B
$6.11M 0.15%
194,565
-3,480
-2% -$117K
NKE icon
105
Nike
NKE
$57B
$6.09M 0.15%
87,275
-14,392
-14% -$1.07M
VEA icon
106
Vanguard FTSE Developed Markets ETF
VEA
$239B
$5.82M 0.14%
97,091
+5,307
+6% +$309K
TXN icon
107
Texas Instruments
TXN
$243B
$5.74M 0.14%
31,237
+1,073
+4% +$210K
IBM icon
108
IBM
IBM
$225B
$5.67M 0.14%
20,085
+4,005
+25% +$1.05M
KLAC icon
109
KLA
KLAC
$240B
$5.65M 0.14%
52,360
+36,930
+239% +$3.45M
MA icon
110
Mastercard
MA
$518B
$5.45M 0.13%
9,588
-2,301
-19% -$1.32M
PG icon
111
Procter & Gamble
PG
$333B
$5.36M 0.13%
34,875
+50
+0.1% +$7.81K
GE icon
112
GE Aerospace
GE
$356B
$5.24M 0.13%
17,421
+3,742
+27% +$1.02M
ALGN icon
113
Align Technology
ALGN
$11.3B
$5.01M 0.12%
40,016
-5,010
-11% -$785K
ORCL icon
114
Oracle
ORCL
$438B
$5.01M 0.12%
17,815
+4,269
+32% +$1.09M
JHMM icon
115
John Hancock Multifactor Mid Cap ETF
JHMM
$6.13B
$5M 0.12%
77,256
-801
-1% -$50.6K
BIIB icon
116
Biogen
BIIB
$32.7B
$4.94M 0.12%
35,297
-5,727
-14% -$774K
FDIS icon
117
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.68B
$4.91M 0.12%
47,687
+44,728
+1,512% +$4.42M
LLY icon
118
Eli Lilly
LLY
$1.05T
$4.74M 0.12%
6,210
+1,551
+33% +$1.15M
VBK icon
119
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$4.63M 0.11%
15,547
+23
+0.1% +$6.64K
MCD icon
120
McDonald's
MCD
$184B
$4.6M 0.11%
15,152
+2,567
+20% +$781K
TSLA icon
121
Tesla
TSLA
$1.4T
$4.37M 0.11%
9,826
+4,747
+93% +$1.65M
VIS icon
122
Vanguard Industrials ETF
VIS
$8.16B
$4.22M 0.1%
14,241
-633
-4% -$183K
SUSA icon
123
iShares ESG Optimized MSCI USA ETF
SUSA
$4.17B
$4.22M 0.1%
31,088
+84
+0.3% +$11K
TPL icon
124
Texas Pacific Land
TPL
$25.5B
$4.12M 0.1%
13,233
+21
+0.2% +$6.61K
VWO icon
125
Vanguard FTSE Emerging Markets ETF
VWO
$127B
$4.01M 0.1%
74,083
+5,534
+8% +$285K

Similar funds

Grimes & Company's Q3 2025 Portfolio in Review

As of Q3 2025, Grimes & Company held 463 positions worth $4.05B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company deployed $164M of net new capital in Q3 2025, opening 50 new positions and adding to 205 existing holdings. Its largest new stake was State Street Materials Select Sector SPDR ETF: 457,276 shares worth $20.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, up from 64% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Short-Term National Muni Bond ETF, an estimated $57.9M trimmed.

  • Grimes & Company's largest Q3 2025 buy was State Street Materials Select Sector SPDR ETF: 457,276 shares worth $20.5M.
  • Grimes & Company added most to Vanguard Morningstar Small-Cap ETF in Q3 2025, an estimated $123M increase.
  • Grimes & Company's biggest Q3 2025 reduction was iShares Short-Term National Muni Bond ETF, cutting an estimated $57.9M.
  • Grimes & Company fully exited Avantis US Small Cap Value ETF in Q3 2025, selling an estimated $443K.
  • Grimes & Company's ten largest holdings make up 45% of its $4.05B portfolio in Q3 2025.
  • Grimes & Company opened 50 new positions and closed 13 in Q3 2025.
  • Grimes & Company's portfolio value rose 10% quarter-over-quarter to $4.05B.

Based on Grimes & Company's 13F filing for Q3 2025, filed 27 Oct 2025.